LINE-1 Deregulation in Ovarian Cancer: Implications for Diagnosis, Prognosis, and Therapeutic Targeting

Molecular Diagnosis and Therapy · Published 2026-06-11 · DOI 10.1007/s40291-026-00861-6

Authors (6)

Nicoletta Bonci, Valentina Schiavoni, Jesmina Rexha, Alice Romagnoli, Roberto Campagna, Giovanni Tossetta

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Bonci, N., Schiavoni, V., Rexha, J., et al. (2026). LINE-1 Deregulation in Ovarian Cancer: Implications for Diagnosis, Prognosis, and Therapeutic Targeting. Molecular Diagnosis and Therapy. https://doi.org/10.1007/s40291-026-00861-6

Related articles

• Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparib · Genome Medicine · 2024 · Cites or is cited by this article
• Clinical, Genetic, Morphological and Functional Correlations in a Large Series of Patients with Primary Ciliary Dyskinesia: A Heterogeneous Disease with a Controversial Diagnosis · Molecular Diagnosis and Therapy · 2025 · Same journal
• Gastric Cancer Treatment New Chapter: Organoid Models Leading Personalized Medicine · Molecular Diagnosis and Therapy · 2025 · Same journal
• Advancing Medulloblastoma Treatment: Molecular Mechanisms, Drug Repurposing, and Precision Therapies · Molecular Diagnosis and Therapy · 2025 · Same journal
• Tividenofusp Alfa: First Approval · Molecular Diagnosis and Therapy · 2026 · Same journal
• Development of a Nomogram to Predict Therapeutic Resistance in Metastatic Melanoma Using Longitudinal ctDNA Kinetics · Molecular Diagnosis and Therapy · 2026 · Same journal
• The Future of Chemogenetics for the Treatment of Spasticity · Molecular Diagnosis and Therapy · 2025 · Same journal
• TROP2-Targeted Therapeutics in Development to Treat Gastrointestinal Tumors · Molecular Diagnosis and Therapy · 2026 · Same journal
• Co-encapsulation in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as an Emerging Therapeutic Strategy · Molecular Diagnosis and Therapy · 2026 · Same journal
• Marnetegragene Autotemcel: First Approval · Molecular Diagnosis and Therapy · 2026 · Same journal